FDA Inspection 1088275 — SOLA Pharmaceuticals LLC
The FDA completed an inspection of SOLA Pharmaceuticals LLC on March 22, 2019 in Baton Rouge, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 22, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Baton Rouge, LA (United States)